Park Nicollet Institute — Minneapolis, Minnesota

Park Nicollet Institute is a clinical research site located in Minneapolis, Minnesota, United States 55416.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Park Nicollet Institute has participated in 7 clinical trials.

Therapeutic areas: Breast Cancer, Asthma, Diabetes Mellitus, Type 2.

Sponsors: Eisai Inc., Amphastar Pharmaceuticals, Inc., Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Park Nicollet Institute?

Park Nicollet Institute has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Park Nicollet Institute conducted?

Park Nicollet Institute has 7 clinical trials on record. Their work covers Breast Cancer, Asthma, Diabetes Mellitus, Type 2.

Is Park Nicollet Institute accredited by Crixeo Health?

Yes — Park Nicollet Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Park Nicollet Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.